Date | Time | Source | Headline | Symbol | Company |
12/09/2008 | 4:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/09/2008 | 4:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/08/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Manag | NYSE:FRX | Forest Road Acquisition Corp |
12/08/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Manag | NYSE:FRX | Forest Road Acquisition Corp |
12/03/2008 | 5:04PM | PR Newswire (US) | Forest Laboratories Responds To Unsolicited Mini-Tender Offer | NYSE:FRX | Forest Road Acquisition Corp |
11/24/2008 | 5:00PM | PR Newswire (US) | USPTO Confirms Validity of Bystolic(R) Patent | NYSE:FRX | Forest Road Acquisition Corp |
11/10/2008 | 4:08PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
10/27/2008 | 8:00AM | PR Newswire (US) | Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infecti | NYSE:FRX | Forest Road Acquisition Corp |
10/23/2008 | 8:00AM | PR Newswire (US) | Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes | NYSE:FRX | Forest Road Acquisition Corp |
10/21/2008 | 2:30PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
10/21/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80 | NYSE:FRX | Forest Road Acquisition Corp |
10/20/2008 | 8:00AM | PR Newswire (US) | FDA Defers Final Action on milnacipran New Drug Application | NYSE:FRX | Forest Road Acquisition Corp |
10/17/2008 | 10:20AM | PR Newswire (US) | Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: ECL, ADM, NI, EGN, AMED, FRX | NYSE:FRX | Forest Road Acquisition Corp |
10/07/2008 | 8:00AM | PR Newswire (US) | Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Const | NYSE:FRX | Forest Road Acquisition Corp |
10/06/2008 | 11:35AM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
10/01/2008 | 4:43PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
09/30/2008 | 2:00AM | PR Newswire (US) | Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Carip | NYSE:FRX | Forest Road Acquisition Corp |
09/23/2008 | 6:07PM | PR Newswire (US) | Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference | NYSE:FRX | Forest Road Acquisition Corp |
09/16/2008 | 12:02PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
09/16/2008 | 11:59AM | Edgar (US Regulatory) | Forest Laboratories Inc - Initial Statement of Beneficial Ownership (3) | NYSE:FRX | Forest Road Acquisition Corp |
09/15/2008 | 8:45AM | PR Newswire (US) | Forest Laboratories, Inc. Appoints Frank Murdolo, Vice President - Investor Relations | NYSE:FRX | Forest Road Acquisition Corp |
09/04/2008 | 1:16PM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
09/04/2008 | 8:00AM | PR Newswire (US) | USPTO Office Action in the Reexamination of U.S. Patent No. 6,545,040 | NYSE:FRX | Forest Road Acquisition Corp |
09/03/2008 | 11:13AM | Marketwired | BellwetherReport.com Analyst Opinions on FRX, KSS, CPS and CAG | NYSE:FRX | Forest Road Acquisition Corp |
09/03/2008 | 2:00AM | PR Newswire (US) | Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive | NYSE:FRX | Forest Road Acquisition Corp |
08/19/2008 | 12:49PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
08/18/2008 | 11:03AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
08/12/2008 | 12:05PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
08/12/2008 | 12:03PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
08/12/2008 | 12:02PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |